SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-022597
Filing Date
2023-06-20
Accepted
2023-06-20 07:11:04
Documents
14
Period of Report
2023-06-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cccc-20230620.htm   iXBRL 8-K 62112
2 EX-99.1 a8k-20230620xexhibit991.htm EX-99.1 13990
6 newlogo.jpg GRAPHIC 8774
  Complete submission text file 0001628280-23-022597.txt   237626

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cccc-20230620.xsd EX-101.SCH 1948
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cccc-20230620_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cccc-20230620_pre.xml EX-101.PRE 13088
8 EXTRACTED XBRL INSTANCE DOCUMENT cccc-20230620_htm.xml XML 11825
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Filer) CIK: 0001662579 (see all company filings)

IRS No.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39567 | Film No.: 231023363
SIC: 2836 Biological Products, (No Diagnostic Substances)